BRISBANE, Australia & MINNEAPOLIS–(BUSINESS WIRE)– Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ THV, a new class of biomimetic heart valve and the world’s only balloon-expandable, single-piece transcatheter aortic valve was implanted in a second successful Valve-in-Valve (ViV) procedure as part of Health Canada’s Special […]
Tag: Anteris
Anteris Technologies Commences US Early Feasibility Study
BRISBANE, Australia & MINNEAPOLIS–(BUSINESS WIRE)–Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ Transcatheter Heart Valve (THV), a new class of biomimetic valve and the world’s only biomimetic, single-piece transcatheter aortic valve, was used to successfully to treat patients as part of the DurAVR™ […]
Anteris Announces Completion of A$35 Million Capital Raise and Provides 2023 Goalposts
Company Funded Through Results of U.S. Early Feasibility Study of DurAVR™ BRISBANE, Australia and EAGAN, Minn.–(BUSINESS WIRE)–Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™, the world’s only balloon-expandable, 3D single-piece biomimetic aortic valve, announced today the completion of a A$35M equity fundraising initiated on February 9th 2023. In […]
Anteris Technologies Announces $20M Private Placement with Perceptive Advisors
BRISBANE, Australia and EAGAN, Minn., March 02, 2022 (GLOBE NEWSWIRE) — Anteris Technologies Ltd (Anteris or the Company) Limited (ASX: AVR) announces the Company has entered a binding agreement to place 1,840,000 new Ordinary Shares (New Shares) raising USD 20 million ($A 28 million) to Perceptive Life Sciences Master Fund, […]
Anteris Technologies to Host TAVR Key Opinion Leader Symposium Moderated by Matt Miksic of Credit Suisse on July 20th, 2020
Next Generation Technologies for the era of TAVR in Younger Low-Risk Patients with Aortic Stenosis BRISBANE, Australia and EAGAN, Minn., July 09, 2020 (GLOBE NEWSWIRE) — Anteris Technologies Limited (ASX:AVR), a structural heart company advancing the DurAVR™ valve, a novel aortic valve replacement solution, announced today that it will host a […]
Admedus Changes Name to Anteris Technologies Ltd
Provides Corporate and Clinical Development Update BRISBANE, Australia and EAGAN, Minn., June 01, 2020 (GLOBE NEWSWIRE) — Admedus Limited (ASX: AHZ), announced today that it has changed the Company’s name to Anteris Technologies Ltd (“Anteris”). As of May 22, 2020 Anteris, is trading on the Australian Securities Exchange under the […]
